Back to 
XTX Topco Ltd
XTX Topco Ltd
KNTE
Showing 0 of 7 quarters
Position history for XTX Topco Ltd's holdings in KINNATE BIOPHARMA INC
As of its Q1 2024 13F, XTX Topco held 104,437 shares of KNTE (Kinnate Biopharma), worth $277,802. XTX Topco's 13F filings listed KNTE from Q2 2023 to Q1 2024, 4 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of KNTE: RA Capital Management, L.P., FMR LLC